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ABSTRACT  
Individuals with advanced HIV infection are prone to other 
infections called opportunistic infections (OIs). This study 
determines the prevalence of OIs among HIV infected patients. 
Five hundred and ninety-six (596) HIV positive Anti-Retroviral 
Therapy (ART) naive subjects referred to the Microbiology and 
Biotechnology Department, National Institute for Pharmaceutical 
Research and Development (NIPRD), Abuja, Nigeria for diagnosis 
were recruited into the study. The socio-demographic and OIs 
isolated from patient’s data were collected and analysed by 
Statistical Product and Service Solution (SPSS) software (version 
17.0, SPSS, Chicago, USA). ANOVA was used to compare the 
groups and (p ≤ 0.05) was set to be statistically significant. 203 
(34.1%) patients presented with OIs. Isolated sputum bacterial 
pathogens included Mycobacterium tuberculosis (4.9%), 
Streptococcus pneumonia (7.4%), Staphylococcus aureus 
(10.0%), Pseudomonas aeruginosa (2.5%). Urinary tract infection 
pathogens are Eschericha coli (19.7%), Klebsiella aerogenes 
(9.9%), Proteus vulguria (2.5%). Stool pathogens are: Salmonella 
typhi (8.9%), Shigella spp (7.9%). High vaginal swab (HVS) 
pathogens are Candida albicans (7.4%), Staphylococcus aureus 
(1.0%) and Streptococcus faecalis (1.5%). The presence of each 
pathogen in the various anatomical sites was statistically 
significant (p< 0.05). The study established OIs among HIV/AIDS 
patients and the need to have treatment options apart from the 
use of ART. 
 
Keywords: Opportunistic infections, NIPRD, immunity, 
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INTRODUCTION 
Individuals with advanced HIV infection are prone to opportunistic 
infections (OIs) and other malignancies due to the opportunity 
offered by depletions of the CD4 T cells count that cause 
continual weakening of the body immune system (Gangadhara 
and Ramesh, 2014). Skin challenges and upper respiratory tract 
infections may develop after an initial asymptomatic phase; and 
these patients begin to lose weight. Frequent feverish conditions, 
fungal or other repeated bacterial infections, and tuberculosis 
(TB) may surface. Although, reports from some studies showed 
that considerable co-morbidities associated with HIV/AIDS are 
candidiasis, proceeded opportunistic infections and pathologic 
organisms which cause gastro intestinal diseases leading to 
chronic diarrhea (Alemayehuel et al., 2017). 
 
Mild OIs and herpes zoster are most commonly found at the initial 
stages of the disease and some life threating infections such as 
central nervous system (CNS), toxoplasmosis and cryptoccocal 
meningitis appear at the advanced stage of the disease 
progression; and there is also possibility of recurrent of bacterial 
pneumonia and tuberculosis at the early as well as late WHO 
stages of the disease (Sharma et al., 2005).  
 
There are over 20 specific OIs that are associated with HIV/AIDS 
infection (WHO, 2007); and patients are usually prone to condition 
called co-infections at the course of their diseases (Losina and 
Freedberg, 2011). HIV affiliated OIs are usually accompany with 
significant morbidity and mortality and almost none can be 
eliminated after some acute infections, thereby requiring life-long 
suppressive therapy. Prevention and treatment of such illness 
with the use of primary prophylaxis is therefore necessary 
(Gangadhara and Ramesh, 2014).  
 
Since the first case of HIV/AIDS the world is still facing continual 
threat with the dreaded virus. However, there has been concerted 
effort globally to thwart the threat (UNAIDS, 2016). This was 
achieved by paying more attention to the clinical management 
and care of the infected individuals using medications in order to 
prolong the life expectance. The prevalence of HIV was estimated 
in Nigeria to be 1.8% in 1991 to 4.5% in 1996, 5.8% in 2001, 
5.0% in 2003 and 4.4% in 2005. However, the national 
prevalence seemed to stabilize between 2005 and 2010 as shown 
by the reported prevalence 4.4% (2005), 4.6% (2008), and 4.1% 
(2010), which ranged from 1.0% in Kebbi State to 12.7% in Benue 
State (FMOH, 2011). Based on the overall national prevalence of 
4.1% obtained in 2010, it is estimated that 3.1million people in 
Nigeria are living with HIV/AIDS in 2010. Of these people, about 
1.5 million require ARV drugs (FMOH, 2010). In 2014, the 
national prevalence was further reduced to 3.0%. Nevertheless, a 
prevalence of 3.0% HIV prevalence implied that over 3.4 million 
Nigerians are currently infected with the virus and about 2.5 
million requiring ART (FMOH, 2015). 
 
Opportunistic infections are so common in HIV/AIDS that they are 
continually with the definitive diseases in both paediatric and adult 
HIV/AIDS patients (UNAIDS, 2016). Therefore, most of the minor 
and major signs and symptoms of the WHO case definition of the 
disease shows the fundamental OIs (WHO, 2007). The Centre for 
Disease Control (CDC) case definition is dependent on the 
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2016). They are found to occur in coexisting at uncommon sites in 
the body of the patient, and produce unusual tissue reactions in 
the body host, now with depleted body immune system 
(Gangadhara and Ramesh, 2014).  
 
Considering the long term introduction and usage of Highly Active 
Anti-retroviral Therapy (HAART), there is significant reduction in 
OIs and AIDS related prognosis (Ayyagari et al., 1999; Sun et al., 
2006; Habtamu et al., 2015). Although, the type of OIs which 
affects people living with HIV/AIDS varies from region to region 
(Sun et al., 2006). Hence, there are significant differences 
between OIs prevalent in Africa and those prevalent in United 
States of America and Europe (Mocroft et al., 2013). Of the all 
HIV/AIDS related infections or diseases, tuberculosis stands most 
common as seen across geographical boundaries and influencing 
about one third of the world’s people living with HIV/AIDS 
(PLWHA) (Sharma et al., 2005). This is may be due its worldwide 
distribution with endemicity in certain areas and cultures (Mocroft 
et al., 2013; Habtamu et al., 2015). Therefore, for the road map of 
HIV/AIDS related morbidity and mortality to be consolidated; their 
frequency, identification and distribution would play important task 
(WHO, 2007).  
 
With the increase rate of reports on HIV/AIDS and OIs, there is 
the need for further study of other diseases affecting HIV/AIDS 
patients and thereby prevent the occurrence of OIs that can result 
in important gains in life expectancy and quality of life among this 
set of group. Thus, the aim of this work was to determine the 
prevalence of opportunistic infections associated with HIV/AIDS 
individuals in Abuja, FCT, Nigeria; so that policy makers, non-
governmental organizations (NGOs) and international donors who 
have related setting can use the research findings for further 
planning and implementation of treatment options related to 
HIV/AIDS and other associated death. 
 
MATERIALS AND METHODS 
 
Study Area 
This study was carried out in Microbiology and Biotechnology 
Department of National Institute for Pharmaceutical Research and 
Development (NIPRD) Idu – Abuja, FCT. The Federal Capital 
Territory (FCT) of Nigeria located on latitude 8o94’N and longitude 
7o09’E.  FCT is served by several health care centres, of which 
NIPRD facility were used for this study. This facility was chosen 
because of high frequency of attendance of clients for HIV 
voluntary counseling and testing (HVCT), rendering of secondary 
health services to the public and referral centre for HIV/AIDS 
treatments PEPFAR in August, 2006 for Abuja and its environs. 
 
Study Design  
This research work was a hospital based prospective study 
conducted from April, through July, 2015. The aim, objectives and 
benefits of the research work were explained in details to the 
participating patients consented to participate in the study. Five 
hundred and ninety-six (596) HIV positive anti-rtroviral therapy 
(ART) naive subjects referred to the Microbiology and 
Biotechnology Department, National Institute for Pharmaceutical 
Research and Development (NIPRD), Idu-Abuja, Nigeria for ART 
initiation. Parameters (CD4+ counts, haematological analysis and 
Viral Load estimations) were included in the study after they were 
given health talk on HIV/AIDS, OIs and consented to participate.  
The recruitment was non-randomized and questionnaires were 
administered on those that consented to participate in the study. 
Data collected after informed consent obtained were strictly 
confidentially and other responses were kept during and after the 
study period. The patients were taken into the study when found 
eligible for ART as per the national guidelines on ART and 
fulfillment of the eligibility criteria for the study. The patients who 
were critically sick and wished not give their consent to be 
included were excluded from the study. 
 
Demographic Information  
The information collected for the purpose of this study from the 
patients includes age, sex, occupation, marital status, educational 
background, phone number and residential address through the 
administration of questionnaires. 
 
Ethical Consideration  
Ethical approval for the study was sought and obtained from 
Health Research and Ethics Committees (HREC) of Federal 
Capital Territory Abuja and was endorsed by the authority of the 
National Institute for Pharmaceutical Research and Development 




The urine, stool and sputum samples were collected in sterile 
universal bottles and a sterile swab stick was used for the 
collection of high virginal swab (HVS). The samples were 
microbiological analyzed for the presences of microorganisms in 
the laboratory using standard laboratory procedures.    
 
Examination of stool samples containers for pathogenic 
protozoan infections. 
Collected stool samples containers were firstly examined 
macroscopically for odor, colour, consistency, (formed unformed, 
watery or mucoid) and for presence of worms, and were also then 
look into microscopically for possible presence of any form or type 
of protozoa, fungi or bacteria. The cysts, larva and eggs of 
parasites were probed by examination of stool samples in eosin 
and iodine preparations and by modified Ziehl Neelsen staining 
for oval Cryptosporidium oocysts (Cheesbrough, 1991). 
 
Bacterial Cultivation and Identification 
The stool samples were sub-cultured in Salmonella Shigella agar 
and incubated at 370C for 24 hours. The colonies with whitish 
appearance were suggestive of presence of pathogens. The 
further identification involved use of biochemical tests 
(Cheesbough, 1991). Drug susceptibility testing was done on all 
the pathogens isolated. 
 
Urine Microscopy and Culture 
Mid-stream urine in sterile containers was obtained from all the 
patients that participated in the study. Each urine sample was 
inoculated onto sterile blood agar and McConkey agar plates and 
incubated at 370C for 24 hours. The isolated pathogens of 
medical significant were identified and characterized according to 
the methods of Cruickshank, (1980); Cheesbrough, (1991). For all 
the identified pathogens, drug susceptibility testing was also done 
using disc diffusion technique. 
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Screening of Sputum Samples  
Sputum samples collected were checked into for appearance: 
purulent, muco-purulent, cheesy, mucoid or muco-salivary, white 
coloured, yellow or bloody or bloodstained and then Giemsa 
stained for sporozoites, trophozoites or cysts of pneumocystis 
carinii as described by Cheesbrough (1991). Purulent, muco-
purulent or cheesy specimens were initially digested with 
Potassium hydroxide solution and incubated for 1 hour to liquefy 
as described by Cheesebrough, (2000) for identification of 
mycelia of fungi. Acid Fast Bacilli (AFB) were then screened for 
using the Ziehl Neelson Staining technique as described by 
Cheesbrough, (1991). 
 
Screening for bacterial and fungal pathogens of the 
respiratory tract 
Digested sputa and nasopharyngeal secretions were cultivated on 
MacConkey, Blood, and Chocolate agar to which optochin discs 
(ethylhydrocuprein hydrochloride) were incorporated, and 
incubated in a carbon dioxide enriched atmosphere (10% CO2) at 
37o C, for 48hr, and look into for growth after overnight incubation 
(Cheesbrough, 1991). The isolates were identified by biochemical 
tests as described by Cheesbrough, (1991).  
Fungal pathogens of the respiratory tract were screened following 
digestion of sputa, naso-pharyngeal secretions and high vaginal 
swabs (HVS) in 5ml of 10% potassium hydroxide solution and 
subsequent examination on physiological saline and Lacto-phenol 
cotton blue for fungal budding cells, hyphae and pseudohyphae. 
The samples were further Giemsa stained and looked into for the 
presence of intracellular yeasts of Histoplasma capsulatum as 
described by Cheesbrough (1991). 
 
Fungal Cultivation and Identification 
The samples containers containing sputa, nasopharyngeal 
secretions and HVS were firstly inoculated onto Sabouraud 
Dextrose Agar (SDA) incorporated with chloramphenicol and 
incubated at both ambient temperature (25-30oC), and at 37o C 
for 2-7days. The rapidly growing colonies on SDA were looked 
into with a hand lens and further on drops of Lactophenol cotton 
blue for grayish-green, velvety powdery textured and V-shaped 
septate hyphal colonies of Aspergillus species. The SDA plate 
growth was then sub-cultured into Corn-Meal Agar (CMA) and 
Brain Heart Infusion (BHI) agar supplemented with 5ml of venous 
blood and chloramphenicol (for ease of isolation of the tissue 
phase of Histoplasma capsulatum), and incubated at both 25-30o 
C and at 37o C for 2-7 days. Discrete colonies from the CMA plate 
were re-inoculated with a straight needle through freshly prepared 
CMA supplemented with 0.02g chloramphenicol, and 1% Tween 
80 (Polysorbate, which reduces surface tension of the media, to 
allow development of pseudo-hyphae, hyphae and 
chlamydospores of yeasts), and incubated at ambient 
temperature for 48 hours, for development of the terminal 
chlamydospores of Candida albicans. The plate was looked into 
daily for submerged growth and further examined on Lactophenol 
preparation using x10 and x40 objective lens for chlamydospores 
and pseudohyphae. Confirmation were carried by the germ tube 
test. Suspected yeast cells from the BHI plates were stained with 
filtered Nigrosin and Loeffler’s alkaline Methylene blue solution 
and observed for thickwalled, nearly spherical budding yeasts 
with gelatinous capsule (which repelled the stain, thereby creating 
a clearing – ‘halo’ effect around the yeast) and further confirmed 
by urease production by inoculation on Christensen’s urea agar 




Socio-demography characteristics data of participants 
A total of five hundred and ninety-six (596) HIV/AIDS patients 
over the age ranges of 18 years presented at ART clinic to be 
initiated on ART at NIPRD Idu-Abuja participated in the study, of 
which 242(40.6%) were males and the rest 354 (59.4%) were 
females. The ratio of male to female was 1: 1.32 and mean age of 
both sexes 38.0 years.  
Of the two hundred and three (203) (34.1%) HIV/AIDS 
seropositive patients that were found infected with one or more of 
the OIs, in relation to age brackets, it was observed that at age 
brackets of (28 – 37) years had the highest rate of 81 (39.9%) of 
isolated OIs patients, followed by (38 – 47) years with 57 (28.1%), 
(18 – 27) years with 39 (19.2%), (48 – 57) years with 23 (11.3%) 
and least observed at above 58 years with 3 (1.5%). More than 
half 149 (73.4%) are from urban settlement while 93 (45.8%) were 
living in a marital association. About 144 (70.9%) of study patients 
that OIs were isolated educational level was above secondary 
school whereas 71 (35.0%), 32 (15.7%), 57(28.1%) and 
43(21.2%) of them were occupationally business, civil servant, 
house wife and others (daily laborer, farmers), respectively shown 
in Table 1. 
 
Table 1: Socio-demographic characteristic of HIV/AIDS ART 
naive patients with isolated OIs at NIPRD, Abuja, during 
presentation. 
 
* Daily laborer, Farming 
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From this study, it was observed that out of the two hundred and 
three (203) (34.1%) HIV seropositive patients that were found 
infected with one or more of the OIs using urine, stool, sputum 
and high vaginal swab specimens; the females 123 (50.6 %) had 
highest prevalence of OIs cases while male had 80 (33.0%). The 
mostly frequently found OIs in both gender was Escherichia coli 
(19.7%) which were followed closely by Staphylococcus aureus 




Figure 1: Gender wise distribution of OIs among HIV/AIDS ART 
naïve patient’s in NIPRD, Abuja 
 




Some frequently occurring bacterial pathogens that were isolated 
from urinary tract specimen included Escherichia coli (19.7%), 
Klebsilla aerogene (9.9%) and Proteus vulgaria (2.5%). All 
infections were concomitant with HIV infection. 
 
Stool specimens: 
The most important pathogen encountered from the stool 
specimen were Salmonella typhi (8.9%) and Shigella Spp (7.9%). 
 
Sputum specimens: 
Some important clinical micro-organisms: Mycobacterium 
tuberculosis (4.9%), Streptococcus pneumonia (7.4%), 
Staphylococcus aureus (10.0%) and Pseudomonas aeruginosa 
(2.5%) were isolated from sputum specimen. 
 
High Vaginal Swab (HVS) specimens: 
The most frequently isolated fungal pathogen in this study was 
Candida albicans (7.4%); and bacterial included Staphylococcus 
aureus (1.0%) and Streptococcus faecalis (1.5%). 
The prevalence of these pathogens isolated from the specimen 
used in the study are shown in figure 2. 
 
 
Figure 2: The prevalence of related OIs among HIV/AIDS ART 
Patient’s in NIPRD, Abuja. 
 
DISCUSSION 
The prevalence of opportunistic infections is very important in 
infection prevention and control like HIV/AIDS. These may due to 
the facts that the infections occurred possibly as a result of 
depletions and concession in the body immunity of the infected 
individual. 
It was observed in this study that gender distribution of male and 
females were infected with various OIs. There was higher 
proportion of females, 354 (59.4%) as compared to males, 
242(40.6%), with the female to male ratio of 1.32 to 1.0.  of 
patients presented with OIs. A total of two hundred and three 
(34.1%) of 596 HIV/AIDS ART naïve infected patients studied 
presented with variety of OIs.  
In this study, it was observed that majority of the patients with 
isolations of OIs were in the age group of 28-37 years and all 
these patients are found below the age of 60 years. This is in 
agreements with the findings of Garcia et al (1998), Who 
observed in their studies that the frequency of OIs are usually 
higher in the sexually active age group of the society. This show 
that a trend of young and productive generation being affected; a 
reflection of the serious challenges that India will face as the 
younger generation work force is affected.  
The findings from this study showed that HIV/AIDS patients in 
Abuja, FCT have a variety of OIs, which included the isolated 
Mycobacterium tuberculosis, Streptococcus pneumonia, 
Staphylococcus aureus, Pseudomonas aeruginosa, Eschericha 
coli, Klebsiella aerogenes, Proteus vulguria, Salmonella typhi, 
Shigella spp, Candida albicans, Staphylococcus aureus and 
Streptococcus faecalis. Although, it was found that the mostly 
frequently OIs in both gender was Escherichia coli (19.7%) which 
were closely followed by Staphylococcus aureus (10.0%) and 
Klebsilla aerogene (9.9%).  
The pattern of these OIs in a particular geographical area helps 
the attending physicians to be on the search for them and take 
prompt treatments options. Concurrently, specific health 
education of people living with HIV/AIDS regarding early detection 
of OIs and importance of antimicrobial prophylaxis to reduce the 
morbidity and mortality can be undertaken (Gangadhara and 
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Ramesh, 2014). 
The prevalence of coliform bacilli: E. coli (19.7%), Proteus 
species (2.5%), Klebsiella aerogene (9.9%) observed in this study 
from the urinary tract, may be extremely associated with the 
malfunction of the urinary tract in the HIV/AIDS infected persons 
examined. This observation is in agreement with the findings of 
Kathleen and Wizburg (1996), on the traditional bacterial 
infections associated with compromised immune system. These 
infections were apparent to be associated with general unhealthy 
sanitary habits, sexual contact and due to infection from feces on 
contact with urethral opening. 
The frequency of HIVAIDS related OIs in this study was even 
higher (83.6%). This finding was in agreement with that of Seyler 
and co-researchers (Seyler et al., 2007). Although, there was no 
information about the burden of OIs during pre-HAART and 
HAART initiation period, the high rate of 47.6% reported by Sun et 
al., (2006) in Taiwan may be attributable to the high OI 
prevalence of 77.7% in their patients before HAART initiations.  
The presences of Staphylococcus aureus (10.0%), Streptococcus 
pneumonia (7.4%), and Pseudomonas aeroginosa (2.5%) in this 
study on sputum, may be seen as OIs in Aids-Defining Conditions 
(ADC); with is in conformity with the report of Duguid et al., (1978) 
and Jacobson et al., (1998), in a case study of HIVAIDS infected 
persons in eastern Nigeria. Although, Staphylococcus aureus was 
identified by Duguid et al., (1978), as a normal flora of the skin, 
urethra and vagina of about 10-30% healthy individuals. The 
Pseudomonas aeruginosa opportunistic abilities was seen by its 
prevalence rate of 2.5%. The organism has ability to cause skin 
infections at burn sites, ulcers, and wounds as its secondary 
invader. It also has high resistance ability to a wide range of 
disinfectants, and antibiotics, and the ease of infectivity was 
therefore established.  
The individual frequency of OIs in this study was low. Although, 
Mycobacterium tuberculosis (TB) was one of the most frequent 
OIs seen in our patients studied; and are not in conformity with 
those reported in patients taking HAART in other low-income 
settings (Sun et al., 2006; Seyler et al., 2007; Mzileni et al., 2007; 
Manosuthi et al., 2007). The prevalence of OIs in this study was 
not similar to what was reported by (Salami et al., 2006; Daniyam 
et al., 2011), in HAART-naive patients in Nigeria. Although, lack of 
change in the frequency of OIs post-HAART compared to the pre-
HAART era has been reported by some authors (Forrest et al., 
1998; Ledergerber et al., 1999; Sun et al., 2006; Manosuthi et al., 
2007). It is of important to mention here that it is unusual of a lot 
of these studies to show that TB was not the commonest OI 
among our patients, despite the well-known high burden of TB in 
Nigeria. Globally, TB diagnosis continuous to remains a serious 
challenge in people living with HIV/AIDS because of the absence 
of classical features, high rate of smear negative disease, and 
relatively high burden of extra-pulmonary disease. 
 
Conclusion  
From the findings, this study has showed the involvement of some 
OIs as aetiologic agents in the prognosis to AIDS in individuals 
living with HIV/AIDS in Abuja, FCT, Nigeria. Therefore, it is 
recommending that early detection of these infections, clinical 
outcome, diagnosis, as well as knowledge on the epidemiology 
and proper treatment options would be useful in the proper 
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